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Objectives: Although retrograde cerebral perfusion has become a popular adjunctive
technique and may improve cerebral ischemic tolerance during hypothermic circu-
latory arrest, direct cerebral metabolic benefit has yet to be demonstrated in human
subjects. We investigated the post-arrest metabolic phenomena with and without
retrograde cerebral perfusion in patients.
Methods: In a prospective randomized trial, 42 patients undergoing aortic surgery
requiring hypothermic circulatory arrest were allocated to receive hypothermic
circulatory arrest alone (n  21) or hypothermic circulatory arrest with additional
retrograde cerebral perfusion (n  21). Circulatory arrest was commenced at 15°C,
and retrograde perfusion was instituted through the superior vena cava at a maxi-
mum jugular bulb pressure of 25 mm Hg. Transcranial, paired, repeated samples of
the arterial and jugular bulb blood were analyzed for oxygen and glucose. Velocity
in the right middle cerebral artery was also measured simultaneously.
Results: There were 3 (7.1%) deaths and 3 (7.1%) episodes of neurologic deficit.
Mean bypass and circulatory arrest duration (in minutes) were similar between
groups (P  .4 and .14). The mean retrograde perfusion duration was 23 minutes.
Post-arrest nasopharyngeal temperature was similar (15.3°C vs 15.3°C). Retrograde
perfusion did not affect post-arrest oxygen extraction, glucose extraction, or jugular
bulb PO2. There was no immediate lactate release immediately after hypothermic
circulatory arrest.
Conclusions: Retrograde cerebral perfusion did not influence immediate post-arrest
nasopharyngeal temperature or cerebral metabolic recovery. The low jugular bulb
PO2 suggests equivalent ischemia. These findings cast doubt on the effectiveness of
retrograde cerebral perfusion as a metabolic adjunct to hypothermic circulatory
arrest.
Hypothermic circulatory arrest (HCA) is a well-established methodto confer cerebral protection during operations involving theaortic arch. Protection of the brain during ischemic arrest isobtained by reducing the temperature, thereby inhibiting meta-bolic activity. This strategy, however, sets time constraints on theoperation and is still associated with significant neurologic mor-
bidity. During the hypothermic arrest period, brain metabolism is not completely
halted but continues in an ischemic environment. This exposes the brain to hypoxia,
hypercapnia, acidosis,1 and elevated levels of excitotoxins2,3 that may cause neu-
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ronal apoptosis and necrosis. Retrospective studies have
shown that HCA at a temperature of 15°C lasting more than
45 minutes is associated with an increased risk of stroke.4
However, a substantial incidence of stroke5 and neuropsy-
chometric deficit6,7 has also been reported for shorter peri-
ods of HCA.
Retrograde cerebral perfusion (RCP) through the supe-
rior vena cava during the HCA period has been introduced
in an attempt to improve cerebral protection during this
vulnerable period. It has been proposed that RCP may
increase cerebral ischemic tolerance and prolong the clini-
cally safe duration of circulatory arrest by providing meta-
bolic support, catabolite removal, and preventing brain re-
warming during the arrest period.8 In addition, RCP may
also provide cerebral protection by means of washout of
gaseous and particulate emboli without the need for blood to
pass through the brain.9
In human subjects, studies of cerebral metabolism have
been used to investigate the adequacy of clinical cardiopul-
monary bypass strategies.10-12 These studies have examined
measures of cerebral blood flow and oxygen extraction as
surrogate indices of cerebral metabolic activity. Further
studies have demonstrated deranged cerebral metabolism
after HCA, comprising increased transcranial oxygen ex-
traction and apparently increased cerebral blood flow.13,14
These changes have been interpreted as a metabolic re-
sponse of the brain to an ischemic insult. Previous human
studies have demonstrated a negative linear correlation be-
tween cerebral oxygenation and duration of circulatory ar-
rest,15 and canine experiments have shown that this cerebral
deoxygenation can be attenuated by the use of RCP.16 We
hypothesized that if RCP provides metabolic support during
circulatory arrest in human subjects, this would be reflected
by an attenuation of the post-HCA metabolic derangement.
The aims of this study were therefore to investigate
cerebral metabolism immediately after HCA and to inves-
tigate the effect of RCP on these changes.
Methods
Study Population
Forty-two consecutive patients (24 male patients) undergoing op-
erations of the aorta requiring HCA were recruited. Patients were
randomized to the use of HCA alone or RCP during HCA (HCA
plus RCP) by means of a minimization technique17 with stratifi-
cation according to age and the proposed extent of aortic replace-
ment, thus anticipating the likely duration of HCA. Patient details
are summarized in Table 1.
The study was approved by the institutional ethics committee,
and written informed consent was obtained from all patients before
the study.
Anesthetic and Perfusion Techniques
Anesthesia was induced with etomidate, fentanyl, and pancuro-
nium and maintained with a standard regimen of intravenous
propofol and alfentanil. All patients were cannulated with a retro-
grade jugular bulb catheter, with placement confirmed by means of
a postoperative skull radiograph. Cardiopulmonary bypass was
instituted with a nonpulsatile roller pump, a membrane oxygen-
ator, and a 40-m arterial line filter with a flow rate of 2.4
L  min1  m2. The blood pressure was maintained at a mean of
50 to 55 mm Hg with -agonists or glycerine trinitrate as appro-
priate. Acid-base balance was maintained with an alpha-stat strat-
egy. Patient temperature was monitored by nasopharyngeal and
esophageal thermistor probes. Core cooling and rewarming with
cardiopulmonary bypass was performed with a water/blood tem-
perature gradient of no more than 10°C. Topical head cooling with
ice was used in all patients before and during the arrest period. In
the first 16 patients, myocardial protection was afforded by means
of intermittent antegrade cold crystalloid cardioplegia. Cold ante-
grade blood cardioplegia was used in the remaining patients.
During cooling, the ascending aorta was crossclamped, allowing
proximal aortic reconstruction. Approximately 20 minutes before
HCA, mannitol at 1 g/kg and dexamethasone at 100 mg were
administered intravenously. Thiopentone was not used. Circula-
tory arrest was instituted at 15°C after repositioning of the patients
in a head-down tilt. After release of the aortic crossclamp and
initial evacuation of blood from the operating field, arch repair was
undertaken under HCA or HCA plus RCP conditions according to
the randomization.
In patients randomized to HCA plus RCP, perfusion through
the superior vena cava was commenced, and flows were adjusted
TABLE 1. Comparison of demographic, pathologic, and op-
erative variables
HCA group RCP group P value
No. 21 21
Age, y (range) 58 (30-70) 63 (23-84)
Male sex 12/21 12/21
Pathology
Degenerative aneurysm 15 14
Chronic type A dissection 1 2
Acute type A dissection 3 2




Syphilitic aneurysm 1 0
Ectodermal dysplasia 1 0
Total 21 21
Redo procedures 0 4
Concomitant CABG 3 0
Concomitant MVR 0 1
Extent of resection
Ascending aorta  root 13 13
Hemiarch  root 5 5
Total arch  root 3 3
Cardiopulmonary bypass,
min (SD)
145 (24.3) 153 (35.7) .401
Initial femoral cannulation 9/21 10/21
Cooling period, min (SD) 58.5 (14.6) 89.0 (40) .02
Cardiac ischemic period,
min (SD)
96.4 (28.0) 110.1 (39) .2
HCA duration, min (SD) 32 (9.0) 27 (12.3) .14
RCP duration, min (SD) — 23 (9.6)
CABG, Coronary artery bypass grafting; MVR, mitral valve replacement.
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to maintain a jugular bulb pressure of 25 mm Hg. This provided
blood flows of between 300 and 600 mL/min. During RCP, drain-
age from the lower body was obstructed by clamping of the
inferior vena cava cannula.
After completion of arch repair, antegrade perfusion was re-
commenced by re-siting the arterial cannula into the arch graft.
This was preceded by rigorous deairing procedures, including
flooding the operative field with 4°C Ringer solution.
Before and after HCA, serum glucose was estimated at 10-
minute intervals. A blood glucose level of greater than 15 mmol/L
prompted commencement of an intravenous infusion of short-
acting insulin.
Cerebral, Hemodynamic, and Metabolic Data
Transcranial Doppler scan monitoring of the right middle cerebral
artery velocity was performed with a SciMed PCDOP 842 device
(SciMed, Bristol, United Kingdom). Traces were recorded onto
videotape and analyzed offline.
Paired arterial and jugular bulb venous samples were drawn
from the arterial and retrograde jugular bulb cannulas, respec-
tively, taking care to avoid artifacts caused by rapid withdrawal.
Blood gas samples were analyzed on a NOVASTAT Profile Ultra
blood gas monitor (Nova Biomedical Corporation, Waltham,
Mass). Blood pH, PCO2, PO2, oxygen saturation, oxygen content,
and glucose and lactate concentrations were determined. Data are
reported immediately before HCA and 1 minute after recommenc-
ing full antegrade perfusion.
During RCP, paired transcranial samples were drawn from the
(afferent) jugular venous bulb line and from the (effluent) common
carotid artery by means of a hand-held, long, soft cannula and
similarly analyzed. These data were compared with data obtained
from contemporaneous afferent blood samples drawn from the
jugular bulb line.
Data Handling and Statistical Treatment
Data were analyzed by using a commercial statistical software
package (SPSS version 7.5, SPSS, Inc, Chicago, Ill) on an IBM-
compatible personal computer (IBM Corp, Armonk, NY). Statis-
tical significance testing was performed by means of unpaired
Student t tests and analysis of variance.
Results
The mean age, extent of resection, and bypass and circula-
tory arrest durations were similar, with no significant sta-
tistical difference between the HCA and RCP groups (Table
1). The duration of cooling was longer in the RCP group.
There were 3 deaths caused by myocardial failure, 2 in
the RCP group and 1 in the HCA group (overall mortality
was 7.1%). The overall incidence of neurologic deficit was
3 (7.1%) of 42 patients, including 1 permanent neurologic
deficit (unilateral sensory loss in the trigeminal nerve dis-
tribution) in the HCA group and 2 transient deficits (obtun-
dation) in the RCP group.
Arterial pH, PO2, PCO2, glucose concentrations, and he-
matocrit levels before the onset of HCA were similar in the
2 groups (Table 2).
At the onset of HCA, nasopharyngeal temperature, jug-
ular bulb PO2, and cerebral oxygen extraction were similar
in the 2 groups (Figures 1 to 4)
On reestablishment of antegrade perfusion, perfusate
conditions were reexamined. There were no significant dif-
ferences in arterial pH, PO2, or glucose concentrations be-
fore or after HCA (Table 2). Arterial PCO2 was significantly
lower in the post-arrest arterial perfusate in the RCP group,
and hematocrit levels were higher.
There was no increase in nasopharyngeal temperature at
the end of the circulatory arrest period in either group
(Figure 1).
There was significant reduction in the jugular bulb PO2,
with associated increases in oxygen extraction and middle
cerebral artery velocity after HCA. The magnitude of these
changes was comparable when HCA was supplemented by
RCP (Figures 2 to 4) Lactate production was not detected
immediately after HCA in either group.
During RCP, transcranial paired sampling showed a sig-
nificant fall of effluent PO2, pH, and glucose concentration
(Table 3). Transcranial oxygen extraction during RCP (3.3
mL/dL; range, 0.7-6.6 mL/dL) was significantly higher than
extraction observed with antegrade perfusion at similar tem-
perature before or after HCA (P  .01, Figure 3).
Discussion
This study demonstrates that HCA is followed by a signif-
icant change in cerebral metabolism. This is manifested by
a reduced jugular bulb PO2, increased transcranial oxygen
extraction, and an increase in middle cerebral artery veloc-
ity. These findings indicate that even relatively short and
clinically safe periods of HCA are associated with a cerebral
ischemic insult, despite temperature suppression of metab-
olism. In addition, our study demonstrates that RCP does
not attenuate the observed changes in cerebral metabolism
after HCA, despite a comparable metabolic profile before
and after arrest. Moreover, the high transcranial oxygen




(mean  SD) P value
Before HCA
pH 7.6 0.3 7.7 0.4 .36
PO2 (mm Hg) 215 34 230 43 .22
PCO2 (mm Hg) 14.6 0.7 15 0.8 .09
Glucose (mmol/L) 8.0 1.5 7.7 1.9 .57
Hematocrit (%) 23 2.1 22 1.5 .08
After HCA
pH 7.6 0.35 7.7 0.45 .42
Po2 (mm Hg) 190 53 205 32 .27
Pco2 (mm Hg) 14.7 0.9 12.6 1.1 .01
Glucose (mmol/L) 7.2 1.2 7.6 1.6 .36
Hematocrit (%) 19 1.7 21 3.2 .02
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extraction observed during RCP infers an ongoing meta-
bolic debt. These findings suggest that the ability of RCP to
provide metabolic support is limited.
In patients undergoing HCA alone, the use of head
packing with ice was not associated with any increase in the
nasopharyngeal temperature. These data are consistent with
animal studies demonstrating the efficacy of topical head
cooling in augmenting protection and preventing rewarming
from the environment.18 Thus, the proposed role of RCP in
maintaining cerebral hypothermia during HCA may be ob-
viated by this simpler technique. However, because perfus-
ate temperature during RCP was maintained at 15°C, any
additional cooling effect of RCP could not be excluded by
this study.
The evidence for cerebral metabolic support by RCP is
species dependent. Although RCP is capable of contributing
to cerebral metabolism in dogs,19 no significant cerebral
blood flow or metabolic benefit has been demonstrated in
Figure 1. Comparison of nasopharyngeal temperature between groups before and at the end of HCA (in degrees
Celsius  SEM).
Figure 2. Jugular bulb PO2 in the 2 groups before and immediately after circulatory arrest (in millimeters of
mercury  SEM).
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baboons.20 Evidence of true cerebral perfusion in human
subjects is also limited. We have previously demonstrated,
using intraoperative technetium 99mTc hexamethyl pro-
pylene amine oxime (99mTc-HMPOA; Amersham Interna-
tional, Ltd, Little Chalfont, United Kingdom) brain imag-
ing, that cerebral perfusion can occur in patients undergoing
RCP21; however, this is variable and cannot be quantified.22
This variation could be explained by the fact that delivery of
blood to the brain during RCP may be hampered by com-
petent internal jugular vein valves, which have been dem-
onstrated in patients23 and cadavers.24
Direct estimates of cortical blood flow with laser Dop-
pler scanning after craniotomy in patients undergoing neu-
rosurgical procedures have shown that RCP provides only
10% of the antegrade baseline cerebral blood flow.25 Re-
versal of the middle cerebral artery flow has also been
demonstrated in some patients during RCP,26-28 and near
infrared spectroscopy studies have suggested that RCP may
slow the decrease in the regional cerebral saturation ob-
served in HCA.26 These findings could be explained by the
presence of venoarterial shunts and arterialization of the
cerebral venous blood volume.20
Figure 3. Transcranial oxygen extraction in the 2 groups before and immediately after circulatory arrest (in
milliliters per deciliters  SEM).
Figure 4. Middle cerebral artery velocity in the 2 groups before and immediately after circulatory arrest (in
centimeters per second  SEM).
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Thus, current data suggest that RCP may provide, at best,
little brain perfusion in human subjects. Nevertheless, even
a small amount of brain perfusion during HCA could the-
oretically have an important effect on substrate supply and
on the removal of catabolites and excitotoxins.29,30 It could
be assumed that during HCA, the brain behaves similarly to
the ischemic penumbra seen in thromboembolic stroke. This
region, unlike the stroke core, does not necrose immediately
and may survive for periods of up to 2 to 4 hours while it
receives a minimal blood supply (10-20 mL/100 g/min).31,32
In addition, in animal models of stroke, infarct volume can
be substantially reduced by lowering the brain temperature
and inhibiting excitotoxins.29,33,34 Although we have not
been able to detect any metabolic effect of RCP, it is
possible that benefit might still accrue if RCP is effective in
reducing excitotoxin accumulation. In addition, interven-
tions that increase actual reversed flow, such as increased
driving pressure or vasodilators, could theoretically exceed
the critical threshold above which a meaningful metabolic
contribution occurs.
In clinical practice RCP has been found to be a safe
technique provided that it is used only at low temperatures
and that the venous driving pressure is not excessive.35
Comparison of clinical outcomes in patients undergoing
RCP with historical control subjects undergoing HCA alone
have suggested an improved stroke and mortality outcome
for the RCP group.36,37 However, these data could be ex-
plained by the fact that patients undergoing HCA alone had
more risk factors for stroke, and the patients who received
RCP may have benefited from improved anesthetic, surgi-
cal, and postoperative techniques compared with the histor-
ical series.
A number of small and often uncontrolled series have
also failed to demonstrate a clear benefit of RCP on HCA
alone.38-40 Finally, although the incidence of stroke and
mortality increases with HCA duration over 45 minutes,4,41
similar findings have been reported with increasing RCP
duration in a large multicenter study.42
One of the limitations of this study consists of the diffi-
culty in obtaining 2 groups of accurately matched patients
because of the great variation in preoperative risk factors,
the limited number of patients treated, and the difficulty in
estimating intraoperative variables prospectively. To reduce
such effects, we adopted a randomization by minimization
method.17 This achieved comparable ranges for the key
factors of age, HCA duration, operation extent, and aortic
disease. However, it is still possible that subtle differences
between groups introduced an inadvertent and unrecognized
bias. For instance, we found that the average cooling period
for patients undergoing RCP was significantly longer than
for the control group because of a higher number of redo
procedures in the RCP group with increased technical com-
plexity of the proximal aortic reconstruction before circu-
latory arrest. Patients undergoing RCP were also slightly
older and had longer myocardial ischemic and bypass times.
They also had shorter HCA durations, a lower arterial PCO2,
and a higher hematocrit level on reperfusion than control
subjects. We believe that these differences would counter-
balance each other and were unlikely to affect the results
overall. Any such bias is likely to be much less than a
comparison with historical control subjects.
Investigating cerebral metabolism in human subjects is a
substantial challenge. In animals direct cannulation of the
arterial inflow and the cerebral venous sinuses enable direct
measurement of flow and metabolic rate. In patients these
methods are not possible, and the rate of consumption of
oxygen and glucose is conventionally calculated from the
product of cerebral blood flow and extraction. Although the
technique of measuring cerebral metabolite extraction by
blood sampling is widely recognized, the accuracy of tech-
niques measuring cerebral blood flow during cardiopulmo-
nary bypass remains controversial.43,44 Currently, there is no
universally accepted method of measuring absolute cerebral
blood flow during cardiopulmonary bypass, especially in
profound hypothermic conditions, during which cerebral
blood flow may be a fraction of normal values. In this study
we did not attempt to measure absolute cerebral blood flow;
rather, we measured changes in cerebral blood flow. Rela-
tive cerebral blood flow has been advocated as a better
solution given the many assumptions that all available
methods have to make.44 The oxygen saturation of jugular
bulb venous blood is a relevant index of cerebral oxygen
extraction at normothermia. During cooling, jugular bulb
oxygen saturation rises as a consequence of adequate or
superadequate cerebral perfusion and increasing affinity of
hemoglobin for oxygen at lower temperatures. We have
therefore reported data on jugular bulb PO2 and transcranial
TABLE 3. Comparison of cerebral inflow and effluent characteristics and transcranial glucose concentration and oxygen
extraction during RCP
Afferent blood Efferent blood P value
pH 7.73 (7.6-7.9) 7.59 (7.5-7.7) .01
PO2 (mm Hg) 226 (183-281) 10.9 (7.0-17.7) .01
PCO2 (mm Hg) 13.7 (10.4-15.9) 17.7 (13.1-24.0) .01
Glucose (mmol/L) 7.3 (5.3-14.4) 6.9 (4.6-12.5) .01
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oxygen extraction to demonstrate the postischemic state of
the brain.
The temperature of the brain is a crucial variable. We
assessed the nasopharyngeal temperature as the best surro-
gate measure of brain temperature. The validity of this
assumption has been tested in patients undergoing neuro-
surgery with HCA.45-47 Although no surrogate measure pre-
cisely correlates with actual brain temperature, especially
with rapid cooling or rewarming, nasopharyngeal tempera-
ture has the best correlation. Because temperature measure-
ments are reported after a prolonged equilibration period of
cooling and after circulatory arrest, we have assumed that
the correlation between brain and nasopharyngeal tempera-
ture would be close.
The risk of cerebral damage after HCA is related to its
duration. In the study population arrest periods were rela-
tively short, and most fell within the clinically acceptable
safe duration. Therefore, it is possible that the effect of RCP
should be specifically examined in patients with longer
HCA periods and that, in such cases, attenuation in the
post-HCA phenomena might be observed. However, no
beneficial effect was observed in comparisons of the small
subgroup of patients with arrest periods of greater than 40
minutes. In addition, if RCP could not attenuate the marked
metabolic derangement of a relatively short period of HCA,
we believe that it would be unlikely to have improved
efficacy over time. However, modifications of RCP that
may increase true reverse of brain blood flow can be satis-
factorily examined by means of the techniques used.
In this study we did not address the potential of RCP to
wash out microscopic or macroscopic emboli or assess the
potential for removal of other factors (eg, excitotoxins) that
may be a clinically relevant advantage of RCP. However,
we did not observe particulate matter in the carotid artery
return during RCP and liberally used irrigation with cold
saline solution during construction of the arch anastomosis
in both groups, allowing aspiration of any debris generated
by surgical manipulation.
This study, which was planned as an observational study,
has produced a negative finding and may be underpowered.
However, animal data have demonstrated significant differ-
ences in cerebral oxygenation between HCA and RCP after
reperfusion. We assumed that differences in cerebral oxy-
genation would be reflected in the measurement of the
postreperfusion jugular bulb PO2. A priori power analysis on
the basis of previous work suggested that a sample size of
21 per group would have a power of 0.8 and an  value of
5% to detect a 15-mm Hg difference in postreperfusion
jugular bulb PO2.16 Our observations show that after HCA,
there is an approximately 60-mm Hg fall in jugular bulb
PO2, and a post hoc analysis suggests that a 30-mm Hg
attenuation of this fall would be detected with 17 patients
per group (power, 0.8; , 5%). Nevertheless, a smaller
attenuation of the postischemic metabolic derangement
could be of clinical relevance, and this study would there-
fore be underpowered to detect this.
In this study RCP did not significantly attenuate the
cerebral metabolic sequelae of HCA. RCP may perfuse the
brain, but the results suggest that this flow is insufficient to
make a major contribution to cerebral oxygenation and that
the brain remains ischemic. It is possible that cerebral
protection by RCP could be improved if greater actual brain
blood flow could be achieved. Despite this, because RCP
may improve cerebral protection through other mecha-
nisms, further studies remain necessary to define its role in
aortic arch surgery.
We thank the operating department technical staff (K. Parkes
and colleagues), anesthetic colleagues, and ITU nursing staff who
supported this project.
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